These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 109892)

  • 21. Effects of dopaminergic system activation on feeding behavior and growth performance of the sea bass (Dicentrarchus labrax): a self-feeding approach.
    Leal E; Fernández-Durán B; Agulleiro MJ; Conde-Siera M; Míguez JM; Cerdá-Reverter JM
    Horm Behav; 2013 Jun; 64(1):113-21. PubMed ID: 23747830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of paraventricular hypothalamic microinjections of phenylpropanolamine and d-amphetamine on mash intake in rats.
    Wellman PJ; Davies BT
    Brain Res Bull; 1990 Aug; 25(2):335-8. PubMed ID: 2224544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.
    Calogero AE; Gallucci WT; Chrousos GP; Gold PW
    J Clin Invest; 1988 Sep; 82(3):839-46. PubMed ID: 2901433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterization of perifornical hypothalamic beta-adrenergic receptors mediating feeding inhibition in the rat.
    Leibowitz SF; Rossakis C
    Neuropharmacology; 1978 Sep; 17(9):691-702. PubMed ID: 29257
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of neuroleptics with central dopamine and noradrenaline receptor blocking properties in the L-DOPA and (+)-amphetamine-induced waking EEG in the rat.
    Monti JM
    Br J Pharmacol; 1979 Sep; 67(1):87-91. PubMed ID: 40644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.
    Zigmond MJ; Stricker EM
    Science; 1973 Nov; 182(4113):717-20. PubMed ID: 4752211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of L-DOPA's antiparkinsonian and dyskinetic effects by α2-noradrenergic receptors within the locus coeruleus.
    Ostock CY; Hallmark J; Palumbo N; Bhide N; Conti M; George JA; Bishop C
    Neuropharmacology; 2015 Aug; 95():215-25. PubMed ID: 25817388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of L-dopa on epinephrine concentration in rat brain: possible role of inhibition of norepinephrine N-methyltransferase by S-adenosylhomocysteine.
    Fuller RW; Hemrick-Luecke SK; Perry KW
    J Pharmacol Exp Ther; 1982 Oct; 223(1):84-9. PubMed ID: 7120131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential and reproductive stage-dependent regulation of vasotocin secretion by catecholamines in the catfish Heteropneustes fossilis.
    Singh RK; Chaube R; Joy KP
    Comp Biochem Physiol A Mol Integr Physiol; 2013 Dec; 166(4):619-26. PubMed ID: 24036478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
    Durham RA; Johnson JD; Moore KE; Lookingland KJ
    Brain Res; 1996 Sep; 732(1-2):113-20. PubMed ID: 8891275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. L-dopa induces opposing effects on pain in intact rats: (-)-sulpiride, SCH 23390 or alpha-methyl-DL-p-tyrosine methylester hydrochloride reveals profound hyperalgesia in large antinociceptive doses.
    Paalzow GH
    J Pharmacol Exp Ther; 1992 Nov; 263(2):470-9. PubMed ID: 1432683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A probable role for norepinephrine in feeding after hypothalamic injection of morphine.
    Tepperman FS; Hirst M; Gowdey CW
    Pharmacol Biochem Behav; 1981 Oct; 15(4):555-8. PubMed ID: 7291259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of the different enzymatic steps in the synthesis of brain amines and memory (CAR) in hypobaric hypoxic rats treated and untreated with L. dopa.
    Boismare F; Le Poncin-Lafitte M; Rapin JR
    Aviat Space Environ Med; 1980 Feb; 51(2):126-8. PubMed ID: 7362556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-dopa facilitates the release of endogenous norepinephrine and dopamine via presynaptic beta 1- and beta 2-adrenoceptors under essentially complete inhibition of L-aromatic amino acid decarboxylase in rat hypothalamic slices.
    Goshima Y; Nakamura S; Misu Y
    Jpn J Pharmacol; 1990 May; 53(1):47-56. PubMed ID: 1972204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
    Nguyen TB; Angers M
    Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-Dopa repairs deficits in locomotor and investigatory exploration produced by denervation of catecholamine terminal fields in the forebrain of rats.
    Fink JS; Smith GP
    J Comp Physiol Psychol; 1979 Feb; 93(1):66-73. PubMed ID: 447889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dietary tyrosine on L-dopa- and amphetamine-induced changes in locomotor activity and neurochemistry in mice.
    Thurmond JB; Freeman GB; Soblosky JS; Ieni JR; Brown JW
    Pharmacol Biochem Behav; 1990 Oct; 37(2):259-66. PubMed ID: 2080188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: an immunohistochemical study.
    Arai R; Karasawa N; Nagatsu I
    Brain Res; 1996 May; 722(1-2):181-4. PubMed ID: 8813364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of L-dopa on glutamate decarboxylase activity in the hypothalamic and amygdaloid nuclei.
    Itoh M; Nohtomi A; Yufu N; Uchimua H
    J Pharm Pharmacol; 1984 May; 36(5):336-7. PubMed ID: 6145774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.